Rapid achievement of MR(4.5) after switching from imatinib to nilotinib in patients with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal Meeting Abstract


Authors: Ritchie, E.; Deininger, M.; Erba, H.; Savona, M.; Paley, C.; Dautaj, I.; Mauro, M.
Abstract Title: Rapid achievement of MR(4.5) after switching from imatinib to nilotinib in patients with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
Meeting Title: 4th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 16
Issue: Suppl. 2
Meeting Dates: 2016 Sep 7-10
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2016-09-01
Start Page: S63
Language: English
ACCESSION: 117709194
DOI: 10.1016/j.clml.2016.07.091
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Accession Number: 117709194 -- Entry Date: In Process -- Revision Date: 20160829 -- Publication Type: Meeting Abstract: CML-124 -- Supplement Title: Sep2016 Supplement 2 -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro